MYTH #1: The current schedule loss of use guidelines “reflect thirty - year old medical assumptions” and thus lead to inappropriate calculation of SLU awards.
The Board’s SLU guidelines, much like the 2012 update to the non - schedule permanency guidelines, are almost entirely indexed to measurements of a person’s residual functional capacity in determining permanency ratings, and are based little if at all on the nature of any particular pathology or procedure. 1 As such, any improvements in medical technology, the result of which would be a better outcome for the patient, will automatically by the very logic and structure of the current guidelines result in a lower severity or pe rcentage loss. A n accounting for improvement s in medical technology is thus already built in to the cur rent guidelines.
